MCRBNasdaq United States
Market cap
$48.414 M
$4.87 +1.04%
Close of 7 Aug 2026
Revenue
$789.0K
#3521 by revenue
Earnings
$5.70M
#2176 by earnings
Shares outstanding
9,941,261
Latest filing cover page
P/E ratio
8.5
Cap ÷ net income
Where these numbers come from
Share counts and financials for Seres Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.